Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05214066
What this trial is testing

Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

Who this might be right for
aGVHDcGVHD
Chinese PLA General Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT00967343
What this trial is testing

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Myeloid LeukemiaLymphoblastic LeukemiaLymphoma+3 more
Kiadis Pharma 40
Post-approval studies (Phase 4)UnknownNCT04867720
What this trial is testing

Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients

Who this might be right for
Liver Transplant
Chong Kun Dang Pharmaceutical 112
Testing effectiveness (Phase 2)Study completedNCT02737748
What this trial is testing

TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds

Who this might be right for
Donor Site Complication
Transwell Biotech Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT01491958
What this trial is testing

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Ohio State University Comprehensive Cancer Center 40
Not applicableStudy completedNCT07200583
What this trial is testing

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Who this might be right for
Hematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more
Ting YANG 50
Not applicableStudy completedNCT00936078
What this trial is testing

The Living Kidney Donor Safety Study

Who this might be right for
Living Kidney Donation
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1,438
Post-approval studies (Phase 4)Study completedNCT02677181
What this trial is testing

Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

Who this might be right for
aGVHD
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05068830
What this trial is testing

Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Norwegian University of Science and Technology 60
Post-approval studies (Phase 4)Study completedNCT02152345
What this trial is testing

Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

Who this might be right for
Implant or Graft; Rejection
Columbia University 57
Not applicableUnknownNCT00813579
What this trial is testing

Study of Prospective Assessment of Living Kidney Donors: Pre and Post Donation

Who this might be right for
Kidney Donation
Mansoura University 80
Early research (Phase 1)WithdrawnNCT04556266
What this trial is testing

A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies

Who this might be right for
LeukemiaLymphomaLymphoma, B-Cell
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Large-scale testing (Phase 3)Looking for participantsNCT07702578
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Post-approval studies (Phase 4)Study completedNCT02660684
What this trial is testing

Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor

Who this might be right for
Graft Versus Host Disease
Astellas Pharma Korea, Inc. 39
Testing effectiveness (Phase 2)WithdrawnNCT00004878
What this trial is testing

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00586690
What this trial is testing

Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT

Who this might be right for
Lymphoma
David Rizzieri, MD 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Early research (Phase 1)Active Not RecruitingNCT05507827
What this trial is testing

Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL

Who this might be right for
Lymphoid Leukemia
Stanford University 22
Testing effectiveness (Phase 2)UnknownNCT00371904
What this trial is testing

Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients

Who this might be right for
Kidney Transplantation
Hunter and New England Health 192
Next Page